Multiple U.S. military services are implementing handheld blood testing devices to diagnose traumatic brain injuries in combat zones. The devices have been deployed to the Middle East as troops face high rates of brain injuries from recent conflicts.

The i-STAT Alinity device can diagnose traumatic brain injuries in 15 minutes by measuring brain-specific proteins that secrete through the blood-brain barrier following trauma. If the proteins measured by the device are elevated, it indicates the patient has sustained a traumatic brain injury, and the device can detect acute brain injuries up to 24 hours after initial trauma.

The i-STAT Alinity device has been sent to the Middle East, where U.S. Central Command officials stated that a majority of the hundreds of troops injured in the Iran conflict have suffered traumatic brain injuries. Jessica Peck, Colonel and Surgeon for the 10th Army Air and Missile Defense Command, noted the specific vulnerability of certain units. "In Central Command, we're seeing disproportionately high traumatic brain injury rates in air defense," Peck said.

She added that these assignments place unique demands on service members. "These jobs demand extremely high cognitive performance," Peck said. Peck explained the operational consequences of undiagnosed injuries, stating, "Even a mild traumatic brain injury can significantly degrade effectiveness, impacting coordination, emotional regulation, spatial awareness, and decision-making."

The Army stated that the i-STAT test is one of the first service-funded research programs to start at the Walter Reed Army Institute of Research, pass clinical trials, receive Food and Drug Administration approval, and deploy to combat. Bradley A. Dengler, Lieutenant Colonel and Neurosurgery Consultant to the Army Surgeon General, addressed the historical challenges in identification. "Historically, we've missed a lot of these injuries," Dengler said. The implementation represents a shift from prior diagnostic methods, as military medical providers historically relied on the Military Acute Concussion Evaluation, a subjective test focused on memory and concentration, to assess for traumatic brain injuries.

The limitations of the prior testing method have been documented by medical personnel in the field. "People can intentionally perform better or worse depending on what they want the outcome to be," Peck said regarding the subjective evaluation. Peck noted that the issue is particularly acute among elite units, stating, "A lot of special operations personnel have memorized the word lists, so they can essentially 'beat' the test."

Navy corpsmen and members of the Defense Health Agency evaluated several traumatic brain injury diagnostic devices at Camp Lejeune, North Carolina, late last month. The Defense Health Agency stated that providing troops with access to frontline neurological assessments is a top priority for the agency. Damien Hoffman, Product Manager for the Defense Health Agency Warfighter Readiness, Performance and Brain Health team, described the agency's approach to implementation.

"Our process is a continuum, with flexibility to evolve alongside emerging threats and meet the needs of front-line warfighters, combatant commands and joint staff," Hoffman said. He added, "Our goal is to rapidly develop a TBI assessment capability at the speed of relevance and these touchpoints are imperative to achieving that goal."

Blood samples for the diagnostic devices will be refrigerated with frontline Role 1 medical units to preserve sample integrity. The deployment comes as the Pentagon faces a substantial historical burden from brain injuries, with troops having reported approximately 500,000 traumatic brain injuries since 2000, according to Defense Health Agency statistics. During the Global War on Terrorism, 68% of troops evacuated for head CT scans ultimately returned to duty, according to an Army press release.

The implementation of the i-STAT Alinity device addresses a longstanding gap in battlefield medicine identified by medical officials. The device's ability to produce objective biomarker results in 15 minutes, compared to subjective cognitive evaluations, provides commanders with diagnostic certainty that was previously unavailable in deployed settings. The approximately 500,000 reported traumatic brain injuries since 2000 and the high rates observed in the Iran conflict illustrate the scale of the issue affecting force readiness.

The Army's development pathway for the i-STAT test, from Walter Reed Army Institute of Research through FDA approval to combat deployment, establishes a framework for future medical technology integration. The Defense Health Agency's evaluation of multiple devices at Camp Lejeune indicates ongoing refinement of diagnostic protocols. Blood sample storage at Role 1 medical units ensures the testing capability reaches the most forward-deployed personnel, while the 24-hour detection window accommodates the delayed symptom onset common in combat trauma scenarios.